NCT02080455View on ClinicalTrials.gov

Evaluate the Effect of Atorvastatin on the Pharmacokinetics of Lomitapide in Healthy Subjects.

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

January 27, 2014

Primary Completion Date

March 7, 2014

Study Completion Date

March 7, 2014

Conditions
Effect of Atorvastatin on the Pharmacokinetics of Lomitapide
Interventions
DRUG

lomitapide

20 mg dose

DRUG

Atorvastatin

80 mg

Trial Locations (1)

75247

Covance Clinical Research Unit, Inc, Dallas

Sponsors
All Listed Sponsors
lead

Aegerion Pharmaceuticals, Inc.

INDUSTRY